Showing results (2001-2010 of 2,338) with videos related to

Sort By:
Pageof 234
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
The Journal of Rheumatology|November 15, 2024
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease RegistryPiero Ruscitti, Ilenia Di Cola, Antonio Vitale, et al.
Rheumatology (Oxford, England)|September 30, 2025
Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease RegistryLaura Calabrese, Martina D'Onghia, Alessandra Cartocci, et al.
Internal and Emergency Medicine|October 12, 2023
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease RegistryPaola Triggianese, Antonio Vitale, Giuseppe Lopalco, et al.
Frontiers in Medicine|July 28, 2022
Development and Implementation of the AIDA International Registry for Patients With VEXAS SyndromeAntonio Vitale, Valeria Caggiano, Francesca Della Casa, et al.
JAMA|March 11, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial, James D Berry, Nicholas J Maragakis, et al.
Internal and Emergency Medicine|July 13, 2022
Development and implementation of the AIDA International Registry for patients with Behçet's diseaseAntonio Vitale, Francesca Della Casa, Gaafar Ragab, et al.
JAMA Neurology|March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial, Jinsy Andrews, Sabrina Paganoni, et al.
Rheumatology (Oxford, England)|January 20, 2025
The clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease RegistryPiero Ruscitti, Antonio Vitale, Ilenia Di Cola, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Pageof 234